295 related articles for article (PubMed ID: 23923969)
1. Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients.
Koppula S; Yost SE; Sussman A; Bracamonte ER; Kaplan B
Clin Transplant; 2013; 27(4):591-7. PubMed ID: 23923969
[TBL] [Abstract][Full Text] [Related]
2. De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.
Shochet L; Kanellis J; Simpson I; Ta J; Mulley W
Nephrology (Carlton); 2017 Feb; 22 Suppl 1():23-27. PubMed ID: 28176480
[TBL] [Abstract][Full Text] [Related]
3. The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy.
Wu K; Budde K; Schmidt D; Neumayer HH; Lehner L; Bamoulid J; Rudolph B
Clin Transplant; 2016 Feb; 30(2):105-17. PubMed ID: 26448478
[TBL] [Abstract][Full Text] [Related]
4. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
[TBL] [Abstract][Full Text] [Related]
5. De Novo Thrombotic Microangiopathy Immediately After Kidney Transplant in Patients Without Apparent Risk Factors.
Patel A; Knorr JP; Campos S; Khanmoradi K; Zaki RF; Bradauskaite G
Exp Clin Transplant; 2016 Apr; 14(2):230-4. PubMed ID: 26030297
[TBL] [Abstract][Full Text] [Related]
6. De novo thrombotic microangiopathy induced by cytomegalovirus infection leading to renal allograft loss.
De Keyzer K; Van Laecke S; Peeters P; Vanholder R
Am J Nephrol; 2010; 32(5):491-6. PubMed ID: 20975262
[TBL] [Abstract][Full Text] [Related]
7. De novo thrombotic microangiopathy after kidney transplantation.
Garg N; Rennke HG; Pavlakis M; Zandi-Nejad K
Transplant Rev (Orlando); 2018 Jan; 32(1):58-68. PubMed ID: 29157988
[TBL] [Abstract][Full Text] [Related]
8. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report.
Chandran S; Baxter-Lowe L; Olson JL; Tomlanovich SJ; Webber A
Transplant Proc; 2011 Jun; 43(5):2097-101. PubMed ID: 21693335
[TBL] [Abstract][Full Text] [Related]
9. A case of tacrolimus-associated thrombotic microangiopathy after ABO-blood-type-incompatible renal transplantation.
Takeda A; Ohtsuka Y; Horike K; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
Clin Transplant; 2011 Jul; 25 Suppl 23():15-8. PubMed ID: 21623908
[TBL] [Abstract][Full Text] [Related]
10. Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombotic microangiopathy.
Ashman N; Chapagain A; Dobbie H; Raftery MJ; Sheaff MT; Yaqoob MM
Am J Transplant; 2009 Feb; 9(2):424-7. PubMed ID: 19120084
[TBL] [Abstract][Full Text] [Related]
11. A case of progressive thrombotic microangiopathy after ABO-incompatible renal transplantation.
Miura M; Fujita H; Suzuki A; Kubota KC; Fukasawa Y; Shimoda N; Tsuchihashi S; Tamaki T
Clin Transplant; 2011 Jul; 25 Suppl 23():19-22. PubMed ID: 21623909
[TBL] [Abstract][Full Text] [Related]
12. Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report.
Safa K; Logan MS; Batal I; Gabardi S; Rennke HG; Abdi R
Clin Nephrol; 2015 Feb; 83(2):125-9. PubMed ID: 24495904
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic microangiopathy after kidney transplantation.
Ponticelli C; Banfi G
Transpl Int; 2006 Oct; 19(10):789-94. PubMed ID: 16961769
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature.
Java A; Edwards A; Rossi A; Pandey R; Gaut J; Delos Santos R; Miller B; Klein C; Brennan D
Transpl Int; 2015 Sep; 28(9):1121-5. PubMed ID: 25864519
[TBL] [Abstract][Full Text] [Related]
15. De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus.
Cortina G; Trojer R; Waldegger S; Schneeberger S; Gut N; Hofer J
Pediatr Nephrol; 2015 Apr; 30(4):693-7. PubMed ID: 25577332
[TBL] [Abstract][Full Text] [Related]
16. De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy.
Schwimmer J; Nadasdy TA; Spitalnik PF; Kaplan KL; Zand MS
Am J Kidney Dis; 2003 Feb; 41(2):471-9. PubMed ID: 12552512
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumab.
Wilson CH; Brown AL; White SA; Goodship TH; Sheerin NS; Manas DM
Transplantation; 2011 Oct; 92(8):e42-3. PubMed ID: 21989273
[No Abstract] [Full Text] [Related]
18. Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report.
Merola J; Yoo PS; Schaub J; Smith JD; Rodriguez-Davalos MI; Tichy E; Mulligan DC; Asch W; Formica R; Kashgarian M; Kulkarni S
Transplant Proc; 2016 Nov; 48(9):3106-3108. PubMed ID: 27932157
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid syndrome in renal transplantation.
Barbour TD; Crosthwaite A; Chow K; Finlay MJ; Better N; Hughes PD; Cohney SJ
Nephrology (Carlton); 2014 Apr; 19(4):177-85. PubMed ID: 24548061
[TBL] [Abstract][Full Text] [Related]
20. Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.
Ikeda T; Okumi M; Unagami K; Kanzawa T; Sawada A; Kawanishi K; Omoto K; Ishida H; Tanabe K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():35-40. PubMed ID: 26970541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
